Medroxy<wbr/>progesterone 17-<wbr/>acetate

Medroxyprogesterone 17-acetate

CAT N°: 23664
Price:

From 92.00 78.20

Medroxyprogesterone 17-acetate is a synthetic progestogen.{37205},{37206},{37207} It prevents fertilization and increases the rate of transport of eggs from the fallopian tubes to the uterus in female ferrets when administered prior to ovulation.{37205} Medroxyprogesterone 17-acetate reversibly blocks ovulation in rats when injected on the last day of diestrus.{37206} It also has anti-androgenic activity in rats, decreasing plasma testosterone (Item Nos. 15645 | ISO60154) levels via induction of hepatic testosterone reductase activity.{37207} Medroxyprogesterone 17-acetate exhibits immunosuppressive effects in vitro and in vivo, inhibiting the production of IFN-? by CD2/CD3/CD28-stimulated peripheral blood mononuclear cells (PBMCs) at concentrations ?10 nM and extending the survival of rabbit skin allografts.{37208},{37209} Injectable formulations containing medroxyprogesterone 17-acetate have been used as contraceptives.{37210}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 17-(acetyloxy)-6?-methyl-pregn-4-ene-3,20-dione
  • Correlated keywords
    • amen aragest 5 asconale CBP1011 CBP-1011 clinofem colirest curretab cycrin DMPA depo-clinovir prodasone provera ralovera subQ 104 progestin promone depot g-farlutal farlutin gestapuran hematrol hysron indivina lutopolar lutoral MAP MPA gyn 5 med-pro metigestrona nadigest nidaxin novo-medrone novomedrone oragest perlutex-leo prempack-C progespon progestalfa progeston progevera proverone repromap repromix sirprogen Sodelut-G veramix 17?-acetoxy-6?-methylprogesterone Medroprogesterone meprate NSC21171 NSC26386 U8839 Depomedroxyprogesterone antiandrogenic IFNg IFN? CD-2 3 28
  • Product Overview:
    Medroxyprogesterone 17-acetate is a synthetic progestogen.{37205},{37206},{37207} It prevents fertilization and increases the rate of transport of eggs from the fallopian tubes to the uterus in female ferrets when administered prior to ovulation.{37205} Medroxyprogesterone 17-acetate reversibly blocks ovulation in rats when injected on the last day of diestrus.{37206} It also has anti-androgenic activity in rats, decreasing plasma testosterone (Item Nos. 15645 | ISO60154) levels via induction of hepatic testosterone reductase activity.{37207} Medroxyprogesterone 17-acetate exhibits immunosuppressive effects in vitro and in vivo, inhibiting the production of IFN-? by CD2/CD3/CD28-stimulated peripheral blood mononuclear cells (PBMCs) at concentrations ?10 nM and extending the survival of rabbit skin allografts.{37208},{37209} Injectable formulations containing medroxyprogesterone 17-acetate have been used as contraceptives.{37210}

We also advise you